CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
18.53
-0.88 (-4.53%)
At close: Dec 5, 2025, 4:00 PM EST
18.40
-0.13 (-0.70%)
After-hours: Dec 5, 2025, 7:05 PM EST
CareDx Employees
As of December 31, 2024, CareDx had 650 total employees, including 644 full-time and 6 part-time employees. The number of employees increased by 7 or 1.09% compared to the previous year.
Employees
650
Change (1Y)
7
Growth (1Y)
1.09%
Revenue / Employee
$550,766
Profits / Employee
$108,386
Market Cap
953.05M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CDNA News
- 12 days ago - SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation - Business Wire
- 26 days ago - CareDx to Participate in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 - Business Wire
- 4 weeks ago - CareDx, Inc (CDNA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - CareDx Announces Third Quarter 2025 Financial Results - Business Wire
- 5 weeks ago - CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer - Business Wire
- 6 weeks ago - CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure - Business Wire